-
WES in HCCOs with varying Doxorubicin resistance
Study
EGAS50000000043
-
Whole Exome Sequencing
Study
EGAS50000000259
-
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
Study
EGAS00001002928
-
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Study
EGAS00001004445
-
Whole genome sequencing data of high-grade serous ovarian cancer samples (set 12)
Dataset
EGAD50000000441
-
Whole genome sequencing data of high-grade serous ovarian cancer samples (set 13)
Dataset
EGAD50000000442
-
ICGC Oesophageal adenocarcinoma - normal samples
Study
EGAS00001000723
-
G-SAM: Transcriptional Evolution of Glioblastomas Treated With Standard of Care
Study
EGAS00001005436
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell RCC -- CA209-010
Study
EGAS00001004291
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell RCC -- CA209-009
Study
EGAS00001004290